Login to Your Account



Other news to note


Friday, December 6, 2013
Auxilium Pharmaceuticals Inc., of Chesterbrook, Pa., said the U.S. District Court for the District of Delaware granted a motion from Upsher-Smith Laboratories Inc., of Maple Grove, Minn., for a summary judgment with respect to its attempts to bring a testosterone gel product to market via the 505(b)(2) pathway using Auxilium’s Testim product as its reference drug.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription